Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H35NO2S.ClH |
| Molecular Weight | 390.023 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCCCCCNCC(O)COC1=CC=C(SC(C)C)C=C1
InChI
InChIKey=QFKMDZYQWDSMPA-UHFFFAOYSA-N
InChI=1S/C20H35NO2S.ClH/c1-4-5-6-7-8-9-14-21-15-18(22)16-23-19-10-12-20(13-11-19)24-17(2)3;/h10-13,17-18,21-22H,4-9,14-16H2,1-3H3;1H
| Molecular Formula | C20H35NO2S |
| Molecular Weight | 353.562 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tipropidil designed for the treatment of cerebral and peripheral vascular diseases. Tipropidil has been investigated because of its expected antihyperviscosity properties. The increase in plasma free fatty acid levels and decrease in lipolytic response were found to be dependent on the amount of Tipropidil administered. Addition of Tipropidil to the in vitro lipolysis system inhibited norepinephrine- and theophylline-induced fatty acid release in a dose-dependent manner. These results suggest a potent inhibitory action for Tipropidyl on fatty acid mobilization in rat adipose tissue.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006629 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6278505 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6278505
Single dose - 50 mg/kg body wt
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:06:46 GMT 2025
by
admin
on
Mon Mar 31 18:06:46 GMT 2025
|
| Record UNII |
34K00NS0TZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055369
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
70895-39-5
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
C033800
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
DTXSID40991185
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
34K00NS0TZ
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111005
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
C77079
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY | |||
|
72175
Created by
admin on Mon Mar 31 18:06:46 GMT 2025 , Edited by admin on Mon Mar 31 18:06:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |